A promising preventative strategy, which has been underutilized, is the reduction of contrast dose. Of all the basic risk factors for contrast nephropathy, including chronic kidney disease, congestive heart failure, hypotension, anemia, age, diabetes mellitus, and contrast volume, contrast volume is the most substantially and practically "modifiable" (2) . Several previous studies have demonstrated a strong association between contrast dose and the occurrence of contrast nephropathy (Table 1 ). This evidence suggests that reducing contrast dose will greatly benefit vulnerable patients and supports the need for contrast-sparing PCI strategies (2-4). From the Cardiac Catheterization Laboratory, Atlanta VA Medical Center and Emory University School of Medicine, Atlanta, Georgia. Dr. Mavromatis has reported that he has no relationships relevant to the contents of this paper to disclose. Imperative of Reducing Contrast Dose in PCI 1295
